Birdwatch Archive

Birdwatch Note

2024-05-03 23:02:13 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

アストラゼネカのワクチンが血小板減少を伴う血栓症(TTS)を起こす事がある、というのは非常に早期に判明していた知見で デマ扱いどころか日本の21年5月の承認時の添付文書に明記してあります(以下2p,8.8 https://www.mhlw.go.jp/content/11123000/000782717.pdf ゼネカ社のHPの21年のワクチン説明文書にも明記してあります https://web.archive.org/web/20210815102507/https://med2.astrazeneca.co.jp/safety/download/VAX02.pdf NHK、朝日など大手新聞やワクチンの紹介の報道でも大々的に報道されており、広く一般に認められ報道されていた知見です。 https://www3.nhk.or.jp/news/special/coronavirus/vaccine/qa/detail/more-detail/qa_05_a19.html https://www.asahi.com/articles/ASP4G3JQQP4BULBJ008.html https://news.yahoo.co.jp/expert/articles/7f74e9c709de6c02935e9ac509a357329444a21f https://answers.ten-navi.com/pharmanews/20913/

Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1786455296648650991

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1786531738694611407
  • noteId - 1786531738694611407
  • participantId -
  • noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
  • createdAtMillis - 1714777333316
  • tweetId - 1786455296648650991
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 1
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • アストラゼネカのワクチンが血小板減少を伴う血栓症(TTS)を起こす事がある、というのは非常に早期に判明していた知見で デマ扱いどころか日本の21年5月の承認時の添付文書に明記してあります(以下2p,8.8 https://www.mhlw.go.jp/content/11123000/000782717.pdf ゼネカ社のHPの21年のワクチン説明文書にも明記してあります https://web.archive.org/web/20210815102507/https://med2.astrazeneca.co.jp/safety/download/VAX02.pdf NHK、朝日など大手新聞やワクチンの紹介の報道でも大々的に報道されており、広く一般に認められ報道されていた知見です。 https://www3.nhk.or.jp/news/special/coronavirus/vaccine/qa/detail/more-detail/qa_05_a19.html https://www.asahi.com/articles/ASP4G3JQQP4BULBJ008.html https://news.yahoo.co.jp/expert/articles/7f74e9c709de6c02935e9ac509a357329444a21f https://answers.ten-navi.com/pharmanews/20913/

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2024-05-03 23:02:13 UTC
(1714777333316)
2024-05-04 04:55:31 UTC
(1714798531022)
CURRENTLY_RATED_HELPFUL 2024-05-04 06:16:06 UTC
(1714803366430)
CURRENTLY_RATED_HELPFUL 2024-05-04 04:55:31 UTC
(1714798531022)
CURRENTLY_RATED_HELPFUL

Note Ratings

rated at rated by
2024-05-03 20:11:27 -0500 Rating Details
2024-05-03 19:58:47 -0500 Rating Details
2024-05-03 19:55:16 -0500 Rating Details
2024-05-03 19:30:28 -0500 Rating Details
2024-05-03 19:10:29 -0500 Rating Details
2024-05-03 19:06:46 -0500 Rating Details
2024-05-03 19:00:04 -0500 Rating Details
2024-05-03 18:57:31 -0500 Rating Details
2024-05-03 18:53:46 -0500 Rating Details
2024-05-03 18:53:08 -0500 Rating Details
2024-05-03 18:51:19 -0500 Rating Details
2024-05-03 18:50:20 -0500 Rating Details
2024-05-03 18:49:23 -0500 Rating Details
2024-05-03 18:48:36 -0500 Rating Details
2024-05-05 03:49:30 -0500 Rating Details
2024-05-04 13:01:04 -0500 Rating Details
2024-05-04 03:31:15 -0500 Rating Details
2024-05-04 02:32:09 -0500 Rating Details
2024-05-03 23:45:15 -0500 Rating Details
2024-05-03 22:57:51 -0500 Rating Details
2024-05-03 21:09:34 -0500 Rating Details
2024-05-03 21:01:58 -0500 Rating Details
2024-05-03 21:01:44 -0500 Rating Details
2024-05-03 20:58:35 -0500 Rating Details
2024-05-03 20:48:32 -0500 Rating Details
2024-05-03 20:47:03 -0500 Rating Details
2024-05-03 20:29:05 -0500 Rating Details
2024-05-03 20:13:11 -0500 Rating Details
2024-05-03 19:39:27 -0500 Rating Details
2024-05-03 19:27:00 -0500 Rating Details
2024-05-03 19:24:59 -0500 Rating Details
2024-05-03 19:09:13 -0500 Rating Details
2024-05-03 19:01:44 -0500 Rating Details
2024-05-03 19:01:26 -0500 Rating Details
2024-05-03 18:59:17 -0500 Rating Details
2024-05-03 18:53:08 -0500 Rating Details
2024-05-03 18:49:34 -0500 Rating Details
2024-05-03 18:47:35 -0500 Rating Details
2024-05-03 18:47:29 -0500 Rating Details
2024-05-03 18:43:34 -0500 Rating Details
2024-05-03 18:42:45 -0500 Rating Details
2024-05-03 18:29:37 -0500 Rating Details
2024-05-04 14:58:16 -0500 Rating Details
2024-05-04 07:56:25 -0500 Rating Details
2024-05-04 07:17:17 -0500 Rating Details
2024-05-04 03:44:43 -0500 Rating Details
2024-05-04 02:20:22 -0500 Rating Details
2024-05-03 22:51:36 -0500 Rating Details
2024-05-03 21:58:46 -0500 Rating Details
2024-05-03 21:40:38 -0500 Rating Details
2024-05-03 20:41:39 -0500 Rating Details
2024-05-05 17:26:13 -0500 Rating Details
2024-05-05 04:05:41 -0500 Rating Details
2024-05-04 12:28:05 -0500 Rating Details
2024-05-04 12:06:51 -0500 Rating Details
2024-05-04 03:06:33 -0500 Rating Details
2024-05-04 02:37:09 -0500 Rating Details
2024-05-03 23:37:10 -0500 Rating Details
2024-05-03 23:05:35 -0500 Rating Details
2024-05-03 21:51:25 -0500 Rating Details
2024-05-03 21:49:08 -0500 Rating Details
2024-05-03 21:11:52 -0500 Rating Details
2024-05-03 21:09:45 -0500 Rating Details
2024-05-03 21:04:34 -0500 Rating Details
2024-05-03 20:47:43 -0500 Rating Details
2024-05-03 20:46:19 -0500 Rating Details
2024-05-03 20:39:43 -0500 Rating Details
2024-05-03 20:21:26 -0500 Rating Details
2024-05-03 20:14:13 -0500 Rating Details
2024-05-03 19:51:55 -0500 Rating Details
2024-05-03 19:50:37 -0500 Rating Details
2024-05-03 19:46:46 -0500 Rating Details
2024-05-03 19:39:40 -0500 Rating Details
2024-05-03 19:16:04 -0500 Rating Details
2024-05-03 19:08:15 -0500 Rating Details
2024-05-03 18:59:47 -0500 Rating Details
2024-05-03 18:57:37 -0500 Rating Details
2024-05-03 18:50:18 -0500 Rating Details
2024-05-03 18:46:06 -0500 Rating Details
2024-05-03 18:45:25 -0500 Rating Details
2024-05-03 18:44:25 -0500 Rating Details
2024-05-03 18:09:35 -0500 Rating Details
2024-05-03 18:04:34 -0500 Rating Details
2024-05-10 02:53:44 -0500 Rating Details
2024-05-05 06:19:52 -0500 Rating Details
2024-05-04 19:37:52 -0500 Rating Details
2024-05-04 12:48:57 -0500 Rating Details
2024-05-04 06:31:44 -0500 Rating Details
2024-05-04 06:31:35 -0500 Rating Details
2024-05-04 03:37:49 -0500 Rating Details
2024-05-04 03:14:07 -0500 Rating Details
2024-05-04 00:13:00 -0500 Rating Details
2024-05-03 23:31:37 -0500 Rating Details
2024-05-03 22:59:57 -0500 Rating Details
2024-05-03 22:17:30 -0500 Rating Details
2024-05-03 20:45:37 -0500 Rating Details
2024-05-03 20:35:37 -0500 Rating Details
2024-05-03 20:25:02 -0500 Rating Details
2024-05-03 20:01:52 -0500 Rating Details
2024-05-03 19:54:43 -0500 Rating Details
2024-05-03 19:44:56 -0500 Rating Details
2024-05-03 19:34:37 -0500 Rating Details
2024-05-03 19:27:06 -0500 Rating Details
2024-05-03 19:26:29 -0500 Rating Details
2024-05-03 19:25:21 -0500 Rating Details
2024-05-03 19:23:46 -0500 Rating Details
2024-05-03 19:15:16 -0500 Rating Details
2024-05-03 19:04:31 -0500 Rating Details
2024-05-03 19:03:42 -0500 Rating Details
2024-05-03 18:56:58 -0500 Rating Details
2024-05-03 18:56:31 -0500 Rating Details
2024-05-03 18:51:59 -0500 Rating Details
2024-05-03 18:49:49 -0500 Rating Details
2024-05-03 18:26:47 -0500 Rating Details
2024-05-03 18:08:36 -0500 Rating Details
2024-05-04 11:18:13 -0500 Rating Details
2024-05-03 19:52:04 -0500 Rating Details
2024-05-03 19:27:15 -0500 Rating Details
2024-05-05 23:42:43 -0500 Rating Details
2024-05-04 23:22:25 -0500 Rating Details
2024-05-04 04:26:25 -0500 Rating Details
2024-05-03 22:54:23 -0500 Rating Details